Trials / Unknown
UnknownNCT05462223
Alucent Vessel Restoration System for AVF
A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Alucent Biomedical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility of the Vessel Restoration System for AVF
Detailed description
A study of the safety and feasibility of the Vessel Restoration System for AVF to promote the physiologic and functional maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Patients with Chronic Kidney Disease Stage V (Pre-dialysis): ACTIVATE AVF
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Alucent Vessel Restoration System for AVF | Alucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components: 1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF 2. VRS Light Fiber 3. VRS Light Source |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2024-05-15
- Completion
- 2024-12-15
- First posted
- 2022-07-18
- Last updated
- 2024-03-13
Locations
12 sites across 2 countries: Australia, Poland
Source: ClinicalTrials.gov record NCT05462223. Inclusion in this directory is not an endorsement.